A Study to Investigate the Safety, Pharmacokinetics (PK), and Efficacy of Garetosmab in Children and Adolescents With Fibrodysplasia Ossificans Progressiva (FOP)
Clinical trial NCT07559513 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07559513
- Sponsor
- Regeneron Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-30
- Primary completion
- 2028-12-10
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.